Several studies have been conducted to investigate molecules such as tissue plasminogen activator (t-PA), plasminogen activator inhibitor-1 (PAI-1), and D-dimer (DD), during cancer progression, evaluating their relationship with tumor size, and their usefulness as prognostic markers. Here, PLAT is linked to cancer.